J Pediatr. 2025 Mar 18:114544. doi: 10.1016/j.jpeds.2025.114544. Online ahead of print.
ABSTRACT
OBJECTIVE: To evaluate a composite metric incorporating the DIGIROP-Birth (DRB) and Neonatal Research Network BPD Outcome Estimator (NRN BPD) for predicting severe retinopathy of prematurity requiring treatment (TR-ROP).
STUDY DESIGN: This was a retrospective cohort study of 990 infants born prematurely undergoing dilated eye exams between January 2010 and August, 2023. We performed a chart review to assess a primary outcome of TR-ROP, and secondary outcome of stage 2 or greater ROP. DRB and 14-day NRN-BPD scores were quantified for each infant, and optimal thresholds for predicting TR-ROP were analyzed using receiver operator characteristic (ROC) curves. Sensitivity and specificity for TR-ROP were assessed.
RESULTS: Of the 990 infants, 364 (36.8%) had stage 2 or greater ROP and 68 (6.9%) had TR-ROP. ROC analysis with (95% CI) showed areas under the curve (AUC) of 0.867 (0.829-0.906) for DRB and 0.845 (0.809-0.881) for NRN-BPD. Optimal cutoff scores were 1.7 for DRB and 40% for NRN-BPD with respective sensitivities of 97% and 96%. Composite screening for babies meeting either cutoff allowed 100% sensitivity for predicting TR-ROP while decreasing number of infants qualifying for screening from 990 to 562 (43% reduction).
CONCLUSIONS: A composite metric using DigiROP-Birth and NRN BPD Outcome Estimator scores may allow an early, simple approach to predict TR-ROP with 100% sensitivity, yet allow significant reduction in the number of infants requiring screening eye exams. Additional large validation studies are needed.
PMID:40113074 | DOI:10.1016/j.jpeds.2025.114544
